Skip to content

The Effects Of Relaxation Training In Women With Primary Dysmenorrhea

The Effects Of Relaxation Training In Women With Primary Dysmenorrhea

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05328869
Enrollment
30
Registered
2022-04-14
Start date
2022-05-15
Completion date
2022-12-15
Last updated
2022-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Dysmenorrhea

Brief summary

The aim of this study was to investigate the effects of relaxation training on menstrual pain severity, menstrual symptoms, impact of quality of life, impact of work/academic performance, impact of social activity level and anxiety level in women with primary dysmenorrhea (PD) complaints.

Detailed description

PD is the cramping pain that comes before or during a menstrual period. Relaxation training contributes to the reduction of stress and pain. Thus, there is a need to investigate the effects of relaxation training in dysmenorrhea.

Interventions

OTHERRelaxation training

Relaxation training will be performed under the supervision of a physiotherapist. The training is carried out from the estimated day of ovulation (cycle length in days minus 14) until the next menstrual period begins

OTHERNo intervention

No intervention will be applied. The natural process will be followed from the estimated day of ovulation (cycle length in days minus 14) until the next menstrual period begins

Sponsors

Ankara Yildirim Beyazıt University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women with primary dysmenorrhea complaint according to the Primary Dysmenorrhea Consensus Guide, * Over 18 years of age, * Having a mean pain intensity of moderate and higher according to the Visual Analogue Scale in the last 6 months, * Having a regular menstrual cycle (28±7 days), * Volunteered to participate in the study.

Exclusion criteria

* Having a pathological history and radiological findings pointing to secondary dysmenorrhea, * Using oral contraceptives/antidepressants at least 6 months, * Receiving hormone therapy, * Undergoing pelvic surgery, * Pregnant, * Giving birth, * Using an intrauterine device, * Having neurological, orthopedic and/or rheumatological diseases * Having a psychiatric disease, * Having a history of malignancy

Design outcomes

Primary

MeasureTime frameDescription
Menstrual pain intensitychange from baseline at an average of 2 weeksMenstrual pain intensity will be evaluated with Visual Analogue Scale. This scale consists of a 10 cm horizontal line. The starting point 0 = no pain, while 10 = unbearable pain. Individuals will be asked to mark on a 10 cm straight line according to the level of pain they feel. Pain intensity will be recorded by measuring the distance between the beginning of the line and the marked place.

Secondary

MeasureTime frameDescription
Menstrual symptomschange from baseline at an average of 2 weeksMenstrual symptoms will be measured with the menstrual symptom questionnaire. Menstrual Symptom Questionnaire is a 24-item self-report scale and each item is scored between 1 (never) and 5 (always). An increase in the mean score indicates an increase in the severity of menstrual symptoms. The total score is 120 points.
Impacts of academic/work performancechange from baseline at an average of 2 weeksImpacts of academic/work performance will be evaluated with Visual Analogue Scale. This scale consists of a 10 cm horizontal line. The starting point 0= means my work/school performance is not affected in any way, while 10= means my work/school performance is greatly affected
Impacts of life qualitychange from baseline at an average of 2 weeksImpacts of life quality will be evaluated with Visual Analogue Scale. This scale consists of a 10 cm horizontal line. The starting point 0 = my quality of life is not affected in any way, while 10 = my quality of life is greatly affected. Individuals will be asked to mark on a 10 cm straight line according to the quality of life they think.
Impacts of social activitychange from baseline at an average of 2 weeksImpacts of social activity will be evaluated with Visual Analogue Scale. This scale consists of a 10 cm horizontal line. The starting point 0 = my social activity is not affected in any way, while 10 = my social activity is greatly affected. Individuals will be asked to mark on a 10 cm straight line according to the social activity they think.
Anxiety levelchange from baseline at an average of 2 weeksAnxiety level will be assessed with the Spielberger State Trait Anxiety Inventory. This inventory is a 40-item self-report inventory designed to measure both state anxiety section (current feelings of apprehension, worry, etc.) and trait anxiety section (continuous feelings of apprehension, worry, etc.). Each section is scored on four levels of anxiety intensity from 1=not at all to 4=very much and with a sum score between 20 and 80. A higher total score indicates more severe anxiety level.

Contacts

Primary ContactSeyda Toprak Celenay
sydtoprak@hotmail.com+90312 906 1000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026